Adicet Bio, Inc. (0HX7.L)
USD 0.92
(-3.81%)
USD 0.92
(-3.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 24.99 Million | 9.73 Million | 17.9 Million | 995 Thousand | 8.18 Million |
| Cost of Revenue | 6.09 Million | 5 Million | - | - | 125 Thousand | 80 Thousand |
| Gross Profit | -6.09 Million | 19.98 Million | 9.73 Million | 17.9 Million | 870 Thousand | 8.1 Million |
| Operating Expenses | 152.03 Million | 92.53 Million | 67.09 Million | 48.04 Million | 31.14 Million | 39.62 Million |
| Selling, General and Administrative Expenses | 26.53 Million | 21.28 Million | 18.15 Million | 13.7 Million | 7.45 Million | 8.56 Million |
| Research and Development Expenses | 106.04 Million | 71.24 Million | 48.94 Million | 34.33 Million | 23.69 Million | 31.06 Million |
| Other Expenses | 19.46 Million | - | - | - | - | - |
| Cost and Expenses | 152.03 Million | 97.54 Million | 71.16 Million | 49.99 Million | 32.38 Million | 39.7 Million |
| Operating Income | -152.03 Million | -72.55 Million | -61.43 Million | -32.09 Million | -31.38 Million | -39.7 Million |
| Interest Expense | 25 Thousand | 80 Thousand | 176 Thousand | 134 Thousand | - | - |
| Income Tax Expense | - | - | -125 Thousand | -2.81 Million | 19 Thousand | 26 Thousand |
| Earnings before Tax | -142.65 Million | -69.79 Million | -62.12 Million | -39.49 Million | -28.11 Million | -37.58 Million |
| Net Income | -142.65 Million | -69.79 Million | -61.99 Million | -36.67 Million | -28.13 Million | -37.61 Million |
| Earnings Per Share Basic | -3.31 | -1.70 | -2.00 | -5.01 | -13.15 | -9.96 |
| Earnings Per Share Diluted | -3.31 | -1.70 | -2.00 | -5.01 | -13.15 | -9.96 |
| Weighted Average Shares Outstanding | 43.04 Million | 41.08 Million | 30.95 Million | 7.31 Million | 2.13 Million | 3.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.04 Million | 41.08 Million | 30.95 Million | 7.31 Million | 2.13 Million | 3.77 Million |
| Gross Margin | - | 0.80 | 1.00 | 1.00 | 0.87 | 0.99 |
| EBIT Margin | - | -2.70 | -5.90 | -1.68 | -30.30 | -4.84 |
| Profit Margin | - | -2.79 | -6.37 | -2.05 | -28.28 | -4.60 |
| EBITDA | -136.53 Million | -64.7 Million | -57.88 Million | -37.4 Million | -30.15 Million | -37.5 Million |
| Earnings Before Tax Margin | - | -2.90 | -6.31 | -1.79 | -31.55 | -4.85 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.6 Million | 1.65 Million | 6.09 Million | 1.68 Million | 2.34 Million | 2.28 Million |
| Gross Profit | -1.6 Million | -1.65 Million | -6.09 Million | -1.68 Million | -2.34 Million | -2.28 Million |
| Operating Expenses | 32.84 Million | 29.22 Million | 126.47 Million | 29.87 Million | 30.45 Million | 32.6 Million |
| Selling, General and Administrative Expenses | 6.94 Million | 5.32 Million | - | 5.11 Million | 4.28 Million | 4.24 Million |
| Research and Development Expenses | 25.9 Million | 23.89 Million | - | 24.75 Million | 26.16 Million | 28.36 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 32.84 Million | 30.87 Million | 132.57 Million | 31.56 Million | 32.79 Million | 34.89 Million |
| Operating Income | -32.84 Million | -30.87 Million | -132.57 Million | -31.56 Million | -32.79 Million | -34.89 Million |
| Interest Expense | - | 2000.00 | 25 Thousand | - | 1000.00 | 4000.00 |
| Income Tax Expense | -1.00 | - | - | - | - | - |
| Earnings before Tax | -29.9 Million | -28.01 Million | -142.65 Million | -29.48 Million | -49.88 Million | -32.4 Million |
| Net Income | -29.9 Million | -28.01 Million | -142.65 Million | -29.48 Million | -49.88 Million | -32.4 Million |
| Earnings Per Share Basic | -0.33 | -0.35 | - | -0.69 | -1.16 | -0.75 |
| Earnings Per Share Diluted | -0.33 | -0.35 | - | -0.69 | -1.16 | -0.75 |
| Weighted Average Shares Outstanding | 90.63 Million | 79.07 Million | 43.04 Million | 43.03 Million | 42.98 Million | 42.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 90.63 Million | 79.07 Million | 43.04 Million | 43.03 Million | 42.98 Million | 42.95 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -31.24 Million | -29.22 Million | - | -29.87 Million | -30.45 Million | -32.6 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
HCLTECH
2880
603041
ISEC
MAVEN
T9Z